ArticleMolecular cancer therapeutics2008

Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesis.

Laura P Stabile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.